Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

J. Shanmuganathan; Morten Schou; Jawad Haider Butt; Christian Torp-Pedersen; Laurids Ostergaard Poulsen; Manan Pareek; Gunnar Gislason; Lars Kober; Dorte Nielsen; Tarec Christoffer El-Galaly; Peter Soegaard; Mamas A Mamas; Phillip Freeman; Kristian Hay Kragholm

doi:10.1093/eurheartj/ehad655.2699

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

J. Shanmuganathan, Morten Schou, Jawad Haider Butt, Christian Torp-Pedersen, Laurids Ostergaard Poulsen, Manan Pareek, Gunnar Gislason, Lars Kober, Dorte Nielsen, Tarec Christoffer El-Galaly, Peter Soegaard, Mamas A Mamas, Phillip Freeman, Kristian Hay Kragholm

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	ehad655.2699
Journal	European Heart Journal
Volume	44
Issue number	Suppl. 2
Number of pages	2
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehad655.2699
Publication status	Published - 9 Nov 2023
Event	ESC Congress 2023 - Amsterdam, Netherlands Duration: 25 Aug 2023 → 28 Aug 2023 https://esc365.escardio.org/esc-congress?text=&docType=DigitalSession&page=1

Conference

Conference	ESC Congress 2023
Country/Territory	Netherlands
City	Amsterdam
Period	25/08/2023 → 28/08/2023
Internet address	https://esc365.escardio.org/esc-congress?text=&docType=DigitalSession&page=1

Access to Document

10.1093/eurheartj/ehad655.2699

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Shanmuganathan, J., Schou, M., Butt, J. H., Torp-Pedersen, C., Poulsen, L. O., Pareek, M., Gislason, G., Kober, L., Nielsen, D., El-Galaly, T. C., Soegaard, P., Mamas, M. A., Freeman, P., & Kragholm, K. H. (2023). Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study. European Heart Journal, 44(Suppl. 2), Article ehad655.2699. https://doi.org/10.1093/eurheartj/ehad655.2699

@article{349aad088fa34865b6f385c23d4ecf70,

title = "Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study",

author = "J. Shanmuganathan and Morten Schou and Butt, {Jawad Haider} and Christian Torp-Pedersen and Poulsen, {Laurids Ostergaard} and Manan Pareek and Gunnar Gislason and Lars Kober and Dorte Nielsen and El-Galaly, {Tarec Christoffer} and Peter Soegaard and Mamas, {Mamas A} and Phillip Freeman and Kragholm, {Kristian Hay}",

year = "2023",

month = nov,

day = "9",

doi = "10.1093/eurheartj/ehad655.2699",

language = "English",

volume = "44",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 2",

note = "ESC Congress 2023 ; Conference date: 25-08-2023 Through 28-08-2023",

url = "https://esc365.escardio.org/esc-congress?text=&docType=DigitalSession&page=1",

}

Shanmuganathan, J, Schou, M, Butt, JH, Torp-Pedersen, C , Poulsen, LO, Pareek, M, Gislason, G, Kober, L, Nielsen, D, El-Galaly, TC , Soegaard, P, Mamas, MA, Freeman, P & Kragholm, KH 2023, 'Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study', European Heart Journal, vol. 44, no. Suppl. 2, ehad655.2699. https://doi.org/10.1093/eurheartj/ehad655.2699

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study. / Shanmuganathan, J.; Schou, Morten; Butt, Jawad Haider et al.
In: European Heart Journal, Vol. 44, No. Suppl. 2, ehad655.2699, 09.11.2023.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

AU - Shanmuganathan, J.

AU - Schou, Morten

AU - Butt, Jawad Haider

AU - Torp-Pedersen, Christian

AU - Poulsen, Laurids Ostergaard

AU - Pareek, Manan

AU - Gislason, Gunnar

AU - Kober, Lars

AU - Nielsen, Dorte

AU - El-Galaly, Tarec Christoffer

AU - Soegaard, Peter

AU - Mamas, Mamas A

AU - Freeman, Phillip

AU - Kragholm, Kristian Hay

PY - 2023/11/9

Y1 - 2023/11/9

U2 - 10.1093/eurheartj/ehad655.2699

DO - 10.1093/eurheartj/ehad655.2699

M3 - Conference abstract in journal

SN - 0195-668X

VL - 44

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 2

M1 - ehad655.2699

T2 - ESC Congress 2023

Y2 - 25 August 2023 through 28 August 2023

ER -

Shanmuganathan J, Schou M, Butt JH, Torp-Pedersen C , Poulsen LO, Pareek M et al. Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study. European Heart Journal. 2023 Nov 9;44(Suppl. 2):ehad655.2699. doi: 10.1093/eurheartj/ehad655.2699